Tag Archives: Jim Hawkins

Natus Appoints Jonathan Kennedy as Senior Vice President and Chief Financial Officer

By Business Wirevia The Motley Fool

Filed under:

Natus Appoints Jonathan Kennedy as Senior Vice President and Chief Financial Officer

SAN CARLOS, Calif.–(BUSINESS WIRE)– Natus Medical Incorporated (NAS: BABY) today announced it has named Jonathan Kennedy, former Chief Financial Officer of Intersil Corporation (NAS: ISIL) , to the position of Senior Vice President and Chief Financial Officer.

Jonathan will report to Jim Hawkins, Chief Executive Officer, and oversee Natus Medical‘s finance and administration, accounting, tax, and treasury functions. He will join Hawkins and John Buhler, President and Chief Operating Officer, on the Natus executive management team that is responsible for directing all aspects of the Company’s strategy, planning and operations.

“Jonathan is an excellent fit for the fast paced culture of Natus,” said Hawkins. “He is a dynamic financial leader with experience in both technology and medical device companies. The experience he has gained over the years in driving acquisition integration efforts, developing and implementing cost reduction initiatives on a worldwide basis, and evolving the finance function in growing enterprises positions him well for Natus.”

“I am pleased to join Natus during an exciting time in the Company’s evolution,” said Mr. Kennedy. “In just a few years, Natus has taken leadership roles in its markets and grown at an extraordinary pace. I look forward to being a part of its already successful team.”

Mr. Kennedy has been Senior Vice President and Chief Financial Officer of Intersil Corporation since April 2009. Prior to that, he was Intersil’s Corporate Controller since 2005 and Director of Finance since 2004. Before joining Intersil, Mr. Kennedy held management roles in Finance and IT with Alcon, Inc. and Harris Corporation. He holds a Bachelor of Science degree in Business Administration and a Master of Science degree in Accounting from the University of Central Florida. Mr. Kennedy also is a Certified Public Accountant.

Mr. Kennedy is expected to join Natus on April 8, 2013. At that time he will assume the CFO role currently held by Steven J. Murphy, who will remain with the Company as Vice President Finance, a position he has held since 2003. During Mr. Murphy’s tenure with the Company it has grown from $30 million in annual revenue to the current run rate of over $350 million.

About Natus Medical Incorporated

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and …read more
Source: FULL ARTICLE at DailyFinance

Natus to Present at Roth 25th Annual OC Growth Stock Conference

By Business Wirevia The Motley Fool

Filed under:

Natus to Present at Roth 25 th Annual OC Growth Stock Conference

– Webcast Available on Company Web Site

SAN CARLOS, Calif.–(BUSINESS WIRE)– Natus Medical Incorporated (NAS: BABY) today announced that the Company is scheduled to present at an upcoming financial conference.

Jim Hawkins, Chief Executive Officer of the Company, will make a presentation at the Roth Capital Partners 25th Annual OC Growth Stock Conference. The conference is being held at the Ritz-Carlton Hotel, Laguna Niguel, California on March 17-20, 2013. Mr. Hawkins is scheduled to present on Monday, March 18 at 9:30 a.m. Pacific Time (12:30 p.m. ET). Attendance at the Roth Capital Partners 25th Annual OC Growth Stock Conference is by invitation only.

Investors may listen to a live webcast via the “Investors” section of the Company’s web site at http://investor.natus.com. Since the presentation will be in a fireside chat format there will be no presentation slides during the webcast. The recorded webcast will be accessible online for at least 30 days.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at www.natus.com.

Natus Medical Incorporated
Steven J. Murphy
Chief Financial Officer
(650) 802-0400
InvestorRelations@Natus.com

KEYWORDS:   United States  North America  California

INDUSTRY KEYWORDS:

The article Natus to Present at Roth 25th Annual OC Growth Stock Conference originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that <a target=_blank …read more
Source: FULL ARTICLE at DailyFinance

Natus Medical Announces Fourth Quarter and Full Year 2012 Results

By Business Wirevia The Motley Fool

Filed under:

Natus Medical Announces Fourth Quarter and Full Year 2012 Results

– Non-GAAP Profit Increases over 100% Leading to Record Fourth Quarter Results

SAN CARLOS, Calif.–(BUSINESS WIRE)– Natus Medical Incorporated (NAS: BABY) today announced financial results for the fourth quarter and full year ended December 31, 2012.

For the fourth quarter ended December 31, 2012, Natus reported revenue of $90.5 million, compared to $64.1 million reported in the comparable quarter of the previous year. The Company reported net income of $4.8 million or $0.16 per diluted share for the fourth quarter 2012, compared to a loss of $17.3 million, or a loss of $0.61 per share, for the fourth quarter of 2011.

For the year ended December 31, 2012, Natus reported revenue of $291.7 million, compared to $232.7 million reported in 2011. Net income was $3.6 million, or $0.12 per diluted share for the year ended December 31, 2012, compared to a loss of $11.7 million, or a loss of $0.41 per share in 2011.

On a non-GAAP basis the Company reported net income of $8.6 million, or $0.29 per diluted share, for the fourth quarter of 2012, compared with net income of $4.1 million, or $0.14 per diluted share, for the fourth quarter of 2011, and net income of $18.4 million, or $0.62 per diluted share, for the full year 2012, compared with net income of $14.0 million, or $0.47 per diluted share, for the full year 2011.

“I am pleased with our record fourth quarter non-GAAP profitability and improved gross profit margin,” said Jim Hawkins, Chief Executive Officer of the Company, “Although delayed orders and softness in some international markets and in our domestic neurology business caused our revenue to come in below guidance, organic revenue still grew approximately 2.3% on a year-over-year basis. We believe our fourth quarter results reflect improved operating efficiencies at Natus. We remain committed to achieving our goal of a 12% non-GAAP pretax profit for fiscal 2013.”

“We successfully integrated the Nicolet sales organization into Natus during the fourth quarter, creating what we believe to be the largest sales and service organization in the world selling into the neurodiagnostic market,” said Hawkins. “After first entering this market only seven years ago, we have now become the worldwide market leader. We are very proud of this accomplishment.”

During January, Natus announced and then successfully closed the acquisition …read more
Source: FULL ARTICLE at DailyFinance